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Available online 10 February 2016Background:Womenwith transposition of the great arteries (TGA) following atrial redirection surgery are at risk
of pregnancy-associated arrhythmia and heart failure. The cardiovascular magnetic resonance imaging (CMR)
characteristics of these women and the relationship of CMR ﬁndings to pregnancy outcomes have not been
described.
Methods:We included 17 women with atrial redirection surgery and CMR within 2 years of delivery.
Results:Allwomenwere asymptomatic at baseline (NewYork Heart Association Class 1). CMR studieswere com-
pletedpre-pregnancy in 3, antepartum/peripartum in 2, and postpartum in 12women. Threewomen (3/17, 18%)
experiencedmajor cardiovascular events related to pregnancy: cardiac arrest (n= 1) and symptomatic atrial ar-
rhythmia (n= 2). Median gestational age at deliverywas 38weeks (24–39weeks) and birthweight was 2770 g
(2195–3720 g). Complicationswere seen in 3 offspring (3/17, 18%): death (n=1) and prematurity (n=2). CMR
characteristics included median right ventricular end diastolic volume 119 mL/m2 (range 85–214 mL/m2) and
median right ventricular ejection fraction (RVEF) 37% (range 30–51%). All womenwith cardiovascular complica-
tions had an RVEF b35% (range 32–34%). The association between RVEF b35% and cardiovascular complications
trended towards statistical signiﬁcance (p= 0.05). No statistically signiﬁcant differences in CMRmeasurements
were found between those with and without neonatal complications.
Conclusions:While the majority of women in this cohort had successful outcomes following pregnancy, impor-
tant cardiovascular complicationswere seen in a signiﬁcantminority, all ofwhomhad anRVEF b35%. The prelim-
inary ﬁndings of our study provide impetus for a larger prospective study to evaluate the prognostic role of CMR
in pregnant women with atrial redirection surgery.
© 2016 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Pregnancy1. Introduction
Right ventricular (RV) systolic dysfunction is a predictor of mor-
tality in non-pregnant adults with a systemic RV [1–3]. Givense; BP, Blood pressure; CMR,
on fraction; NYHA, New York
iastolic volume; RVEF, Right
ady state free precession; TGA,
urgitation.
nue, Toronto, Ontario M5G 2N2,
eliability and freedom from bias
is an open access article under the Cinvariable hemodynamic adaptations to pregnancy, including
prolonged augmentation of cardiac output, pregnant women with
atrial redirection (Mustard or Senning operations) for underlying
transposition of the great arteries (TGA) are at increased risk of
heart failure and arrhythmias [4–7]. Accordingly, contemporary
guidelines suggest in general terms that women with “more than
moderate systemic RV dysfunction” should be advised against preg-
nancy [8]. In contradistinction to those with systemic left ventricular
systolic dysfunction where adverse cardiovascular events in preg-
nancy are known to be more common with an ejection fraction
(EF) less than 40% [9], a precise threshold RVEF for the systemic RV
has not been deﬁned, as all published studies to date have examined
RV function only qualitatively using echocardiography alone [4–7].C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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sidered to be the reference standard for quantiﬁcation of RV volumes
and function [10,11], there are as yet no data available regarding the
CMR characteristics of women following atrial redirection surgery
who undergo pregnancy. In this study, we sought to evaluate the re-
lationship between CMR measurements of systemic RVEF and preg-
nancy outcomes in women who underwent atrial redirection
surgery. We hypothesized that systemic RV dysfunctionwould be as-
sociated with increased risk of maternal and fetal/neonatal adverse
events.
2. Methods
2.1. Study design
Women bornwith complete (D-loop) TGA palliated with atrial redi-
rection surgery were retrospectively identiﬁed from institutional data-
bases at two large Adult Congenital Heart Disease (ACHD) centers in
Toronto (University Health Network/Mount Sinai Hospital) and Boston
(Boston Children's Hospital/Brigham andWomen's Hospital) from1996
until 2011. The study cohort included consecutive women with atrial
redirection surgery who had CMR imaging completed within 2 years
of their delivery date [5]. Patients were excluded if CMR datasets were
incomplete. The Research Ethics Boards of each respective institution
approved this study.
2.2. Patient population
Baseline demographic data were recorded at the ﬁrst clinic visit in
the ﬁrst trimester of pregnancy, including age, New York Heart Associ-
ation (NYHA) functional class, baseline blood pressure (BP), parity
status, associated cardiovascular lesions, medications, and history of
previous cardiovascular events. A completed pregnancy was deﬁned
as N20 weeks gestation. Follow-up clinical data were obtained from
available maternal and pediatric records. Maternal echocardiographic
reports at baseline (prior to pregnancy or in ﬁrst trimester), during
pregnancy (second or third trimester) and post delivery (preferably
N6 months post-partum) were reviewed for ventricular dimensions,
ventricular systolic function, bafﬂe stenosis/leak, outﬂow obstruc-
tion, and degree of tricuspid (systemic atrioventricular) valve regur-
gitation (TR). Severity of TR was graded as none, mild, moderate or
severe according to published criteria [12].
2.3. Adverse outcomes
Adverse outcomes were classiﬁed as cardiovascular, obstetric and
fetal/neonatal outcomes, as previously deﬁned [9]. Cardiovascular
events were deﬁned as: 1) pulmonary edema (documented on chest
radiograph or by crackles heard over more than one-third of posterior
lung ﬁelds), 2) decline in NYHA functional class (≥2 classes) compared
with baseline or need for urgent invasive cardiac procedures during
pregnancy or within 6 months of delivery, 3) sustained tachyarrhyth-
mia requiringmedical therapy or intervention, 4) stroke, and 5) cardiac
arrest and/or cardiac death. Obstetric events were deﬁned as:
1) pregnancy-induced hypertension (blood pressure increase of systolic
pressure ≥30 mm Hg and diastolic pressure ≥15 mm Hg over pre-
pregnancy values), 2) pre-eclampsia (de novo hypertension with BP
≥140 mm Hg or diastolic BP ≥90 mm Hg and accompanied by new-
onset proteinuria N 0.3 g/24 h) or eclampsia [8], 3) pre-term labor,
4) post-partum hemorrhage (blood loss N500 mL after vaginal delivery
or N1000 mL after cesarean section warranting transfusion or a drop in
hemoglobin ≥20 g/L), and 5) non-cardiac obstetric maternal death.
Fetal/neonatal events were deﬁned as: 1) fetal death (categorized as
stillbirth if ≥20 weeks gestation or spontaneous abortion if b20 weeks
gestation) or neonatal death (within 28 days of birth), 2) premature
delivery (b37 weeks of gestation), 3) small for gestational weight(b10th percentile), 4) respiratory distress syndrome, and 5) cerebral
hemorrhage.2.4. Cardiovascular magnetic resonance imaging (CMR)
All CMR studies were performed on commercially available 1.5 T
whole-body scanners with phased array surface coils. All CMR datasets
were acquired in expiratory breath-hold. Retrospectively ECG gated
cine steady state free precession (SSFP) in axial and short-axis slice ori-
entation was acquired with contiguous volume coverage (6–8mm slice
thickness with 2 mm interslice gap). Representative spatial resolution
was 1.3 × 1.3 × 0.8mmand temporal resolutionwas ≤50msec. System-
ic RV and subpulmonic left ventricular volumeswere contoured on SSFP
cine imaging according to previously described methodology [13]. For
the purposes of this study, all images were analyzed by a single experi-
enced observer (LJJ) using a dedicated workstation and commercial
software (Argus, Siemens Healthcare, Erlangen, Germany) in a core
laboratory at the University Heath Network, Toronto. Moderate RV sys-
tolic dysfunctionwas deﬁned as RVEF b35% as previously established in
non-pregnant adults with atrial redirection surgery for complete TGA
[3,14–16].2.5. Statistical analysis
Statistical analysis was performed using SSPS software version 20
(IBM SPSS Statistics 20, 2011). Continuous variables were described
using means and standard deviation or medians and ranges, as ap-
propriate. Categorical variables were described using frequencies
and percentages. Multiple cardiovascular complications in a
woman or multiple fetal/neonatal complications in a baby were
counted as a single outcome event in the mother or child, respective-
ly. The relationship between continuous variables was evaluated
using the Spearman correlation co-efﬁcient. The Mann–Whitney U
test was used to compare CMR measurements in those with and
without adverse events in pregnancy. Univariate logistic regression
analysis was used to examine the effect of RVEF on the odds of an
adverse outcome of pregnancy. Fisher exact test was used to assess
the association between various RVEF thresholds and adverse car-
diovascular events in pregnancy and likelihood ratios were used to
obtain the optimal cut-off. McNemar Bowker test was used to com-
pare echocardiographic parameters at baseline, during pregnancy
and post-partum. A P value b0.05 was considered statistically
signiﬁcant.3. Results
3.1. Clinical characteristics
A total of 17 women with 17 completed pregnancies met inclusion
criteria (7 from Boston and 10 from Toronto). Women with atrial redi-
rection surgery comprised approximately 9% of the overall cohort of
pregnant women with congenital heart disease followed in Boston
[17] and 4% of the pregnant women followed in Toronto [9]. Atrial redi-
rection surgery consisted of theMustard palliation for all of the women
included in this study. None of the women had a Senning procedure for
atrial redirection. All women were asymptomatic at baseline assess-
ment (NYHA functional class 1). Clinical characteristics of the study
population are summarized in Table 1. Echocardiographic data at base-
line, antepartum, and post-partum are shown in Table 2. Themajority of
women did not have appreciable changes in RV global systolic function
on echocardiography, as demonstrated by Fig. 1, although 3 women
with mild RV systolic dysfunction at baseline had moderate RV systolic
dysfunction following pregnancy.
Table 1
Clinical characteristics of the study population (17 women with 17 completed
pregnancies).
Variable Valuea
Maternal data
Age
At Mustard palliation (years) 2.2 (0.6–6)
At delivery (years) 31 (25–37)
At CMR study (years) 32 (27–37)
Cardiac anatomy
Complete TGA with intact septum 12 (70%)
Complete TGA with ventricular septal defect 4 (24%)
Complete TGA with aortic coarctation 1 (6%)
Gravidity
Gravida 1 5 (31%)
Gravida 2 3 (19%)
Gravida ≥3 8 (50%)
Previous abortions
Spontaneous 4 (23%)
Therapeutic 1 (6%)
Functional class at baseline
NYHA class I 17 (100%)
Medications at baseline
Digoxin 1 (6%)
Diuretics 2 (12%)
Beta blocker 0
Angiotensin-converter enzyme inhibitors 4 (24%)
Medications during pregnancy
Digoxin 1 (6%)
Diuretics 2 (12%)
Beta blocker 3 (18%)
Angiotensin-converter enzyme inhibitors 0
Offspring data
Gestational age at delivery (weeks) 38 (24–39)
Birth weight (g) 2770 (2195–3720)
Congenital heart disease in infant 0
CMR, cardiovascular magnetic resonance; TGA, transposition of the great arteries; NYHA,
New York heart association.
a Data given as median (range) or n (%).
Table 2
Echocardiography data in women at baseline, during pregnancy, and post-partuma.
Variable Baseline
(n =
16)
Pregnancy
(n = 16)
Post-partum
(n = 15)
McNemar
Bowker
P-value
Right ventricular function:
Normal 4 4 4 0.506
Mild dysfunction 3 3 0
Moderate dysfunction 7 7 10
Severe dysfunction 2 2 1
TV regurgitation:
None 1 1 1 1
Mild 10 10 10
Moderate 5 5 3
Severe 0 0 1
Subpulmonary obstruction
None 13 13 14 1
Mild 2 2 0
Moderate 1 1 1
Severe 0 0 0
Signiﬁcant pulmonary venous
channel obstruction:
None 16 16 15 1
Signiﬁcant systemic venous
bafﬂe obstruction:
None 16 16 15 1
Bafﬂe leak 1 1 0 1
a A baseline echocardiogram occurred prior to pregnancy or during the ﬁrst trimester;
the echocardiogram closest to deliverywas selected to represent pregnancy; post-partum
echocardiography was completed following delivery.
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A total of 17 CMR studies were available for review and all CMR
datasets were of adequate quality. The CMR data for the study popula-
tion are summarized in Table 3. CMR studies were completed prior to
pregnancy in 3 women (median 8 months, [range 1–10 months]), peri-
partum in 2women (in 1woman 24 h prior to delivery and in 1woman
48 h following delivery), and postpartum in 12 women (median
15 months [range 7–23 months] following delivery).3.3. Clinical events
Outcomes of pregnancy are summarized in Table 4. Adverse
cardiovascular events related to pregnancy occurred in 3 women
(18%) and consisted of sudden cardiac death in 1 woman and atrial
tacharrhythmias in 2 women. One woman had a resuscitated sudden
death event 48 h following delivery. She was found to have pulmo-
nary edema upon admission to hospital and was treated with di-
uretics and angiotensin converting enzyme inhibitor therapy.
Notably, she was on beta-blocker therapy prior to pregnancy, how-
ever medications were discontinued antenatally. She did not have
any additional obstetric or fetal/neonatal complications. A second
woman developed a sustained atrial tachyarrhythmia and was treat-
ed with anti-arrhythmic therapy in the third trimester of pregnancy.
She went on to develop clinical signs of heart failure (there were no
other women in this cohort with congestive heart failure). In addi-
tion to her Mustard palliation she had undergone additional surgery
to repair aortic coarctation at age 1 year. She was not on any medica-
tions prior to pregnancy. A deep venous thrombus was diagnosed
during her pregnancy. There were no adverse events in her offspring.A third woman had a syncopal event at 30 weeks gestation. The epi-
sode was attributed to an atrial tacharrhythmia based on results
from Holter monitoring. Beta-blocker therapy was commenced in
pregnancy but was subsequently discontinued by the patient for un-
clear reasons. An electrophysiology study was recommended follow-
ing pregnancy but was declined. She did not have any adverse
obstetric or fetal/neonatal events.
No major adverse obstetric events were documented in this cohort.
Obstetric complications not considered major adverse events included
premature rupture of membranes in 1 woman and a placental abrup-
tion in 1 woman; each of these obstetric morbidities was associated
with adverse events in the offspring. There were 17 live born infants
in this cohort and complicationswere observed in 3 (18%). Three infants
were born prematurely. One child was born at 36 weeks gestation to a
mother diagnosed with placental abruption at 29 weeks gestation. A
second babywas born at 34weeks gestation andwas admitted to a neo-
natal intensive care unit for further management. The third infant was
born at 24weeks gestation following premature rupture ofmembranes;
this child died of sepsis in the neonatal intensive care unit.
All of the womenwith an adverse cardiovascular event documented
in pregnancy had moderate RV dysfunction with a median RVEF of 33%
(range 32–34%) (CMR studies in thewomenwith cardiovascular events
were performedwithin 24 h of delivery in 1woman, at 22months post-
partum in a second and at 23months post-partum in a thirdwoman). In
the remainder of the event-free population the median RVEF was 37%
(range 30–51%). In a univariate logistic regression model, RVEF was
not a signiﬁcant predictor of adverse outcome (P= 0.214). The associ-
ation betweenmoderate RV dysfunction (RVEF b35%) and the presence
of a cardiovascular event trended towards statistical signiﬁcance (P=
0.051). Various threshold RVEF values between 30 and 50%were exam-
ined to determine the optimal RVEF cut-off associated with cardiovas-
cular complications and the highest likelihood ratio was observed at
RVEF of 35% (LR 6.3, P=0.051). Therewas no statistically signiﬁcant as-
sociation between RVEF and maternal age at the time of delivery (P=
0.941). There was no association between RVEF and adverse outcomes
in offspring. There were no statistically signiﬁcant associations between
other CMR variables (including right/left ventricular volumes and left
ventricular EF) and adverse outcomes of pregnancy.
Fig. 1. Echocardiographic assessment of RV systolic function at baseline, during and following pregnancy (mild, moderate, severe refer to extent of systolic dysfunction).
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Cardiovascular morbidity and mortality after atrial redirection
surgery are known to escalate with advancing age [3]. Cardiovascular
complications, commonly a result of heart failure and/or arrhythmia,
canmanifest during pregnancy and, in somewomen, this declinewill
persist despite completion of pregnancy [4–7]. Although contempo-
rary guidelines caution against pregnancy in women with a systemic
RV and moderate RV systolic dysfunction [8], a more precise deﬁni-
tion has been lacking as assessment of systemic RV function by echo-
cardiography has been mostly qualitative rather than quantitative.
While echocardiographic assessment of systemic RV function can
have important limitations [14], the CMR assessment of the RV has
been shown to be accurate and reproducible [18–20] and is therefore
accepted as the imaging reference standard for measurements with-
in the right heart [10,11]. This is the ﬁrst study to deﬁne the CMR
characteristics of women after atrial redirection surgery undergoing
pregnancy. Although the majority of women studied in our cohort
had uncomplicated pregnancies despite RV systolic dysfunction
(median RVEF 39%), the presence of at least moderate RV systolic
dysfunction (RVEF b35%) in all patients with a major adverse cardio-
vascular event in pregnancy is a noteworthy ﬁnding.Table 3
Cardiovascular magnetic resonance imaging data.
CMR parameter (n = 17) Median (range)
RVEDV (mL) 199 (132–364)
RVEDVi (mL/m2) 119 (85–214)
RVESV (mL) 136 (71–245)
RVESVi (mL/m2) 76 (144–44)
RVSV (mL) 74 (57–138)
RVEF (%) 37 (30–51)
LVEDV (mL) 112 (87–304)
LVEDVi (mL/m2) 62 (55–190)
LVSV (mL) 67 (38–130)
LVEF (%) 60 (45–73)
CMR, cardiovascular magnetic resonance; RVEDV, right ventricular end
diastolic volume; RVEDVi, right ventricular end diastolic indexed volume;
RVESV, right ventricular end systolic volume; RVESVi, right ventricular
end systolic indexed volume; RVSV, right ventricular stroke volume;
RVEF, right ventricular ejection fraction; LVEDV, left ventricular diastolic
volume; LVEDVi, left ventricular end diastolic indexed volume; LVSV, left
ventricular stroke volume; LVEF, left ventricular ejection fraction.Unlike other reports where decline in NYHA functional class was
documented in approximately one third of pregnancies [4,5] and de-
compensated heart failure was observed in 4–7% of women studied [4,
5,21], all of the women studied in our cohort were asymptomatic at
baseline and progressive heart failure was not evident in any of the
pregnancies. Of note, one woman had a resuscitated cardiac death
event. In other respects, our ﬁndings are in keeping with the published
literature. Arrhythmic events in pregnancy are the most common
cardiovascular complication reported in women with atrial redirection
surgery with a prevalence of 6–22% [5,6,21]. In our cohort, atrial tachyar-
rhythmias requiring escalating medical therapy were documented in 2
women (12%) and, although this frequency is in keeping with previous
publications, we note that this may be an underrepresentation of the
true arrhythmia burden given that womenwith pacemakers and/or deﬁ-
brillators were excluded from this CMR-based study. Finally, prematurity
was the most frequent fetal/neonatal complication in our population
(18%), as reported by others [5,21].
While all women with cardiovascular complications in pregnancy
had at least moderate RV systolic dysfunction, RVEF b 35% and occur-
rence of a major adverse cardiovascular event related to pregnancy
approached, but did not reach, statistical signiﬁcance in our study pop-
ulation. This ﬁndingmay reﬂect our small cohort size (type 2 error) and
perhaps the associationwould in fact be signiﬁcant in a larger sample. It
is also worth noting that in the setting of hemodynamically signiﬁcant
tricuspid (systemic atrioventricular valve) regurgitation as is commonly
seen following Mustard palliation, calculated RVEF may in fact be an
overestimate of actual systemic ventricular function in the context ofTable 4
Adverse events related to pregnancy.
Variable Value
Cardiovascular events 3 (18%)
Sustained atrial tachyarrhythmia resulting in heart failure 1 (6%)
Resuscitated sudden cardiac death 1 (6%)
Syncope attributed to atrial tachyarrhythmia 1 (6%)
Fetal/neonatal eventsa 3 (18%)
Premature delivery b37 weeks 2 (12%)
Death 1 (6%)
Obstetric eventsb 0
a Events mutually exclusive.
b Major adverse obstetric events were not observed in this cohort although obstetric
complications observed included abruption in 1 woman and premature rupture of mem-
branes in 1 woman.
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ate tricuspid regurgitation although nowoman had severe tricuspid re-
gurgitation. Furthermore, patients after Mustard surgery are often
limited by chronotropic incompetence and inability to augment stroke
volume given constraints imposed by the caval bafﬂes and, therefore,
an assessment of contractile reserve would perhaps be a higher ﬁdelity
measure in this population as compared with RVEF alone. Other param-
eters whichmay have potential value for stratiﬁcation of cardiovascular
risk in pregnancy (which were not uniformly available in our popula-
tion) include peak aerobic capacity and heart rate response to exercise.
Finally, although advancing age has been established as a risk factor for
functional decline following atrial redirection surgery, in our cohort
there was no relationship between age at the time of delivery and RV
systolic function. Due to the small cohort size, we were unable to adjust
for such parameters in addition.
Findings from this study may have implications for clinical practice
in the following ways. Although CMR can provide important informa-
tion regarding RV systolic function, particularly in the setting of a
systemic RV, we found that CMR studies were infrequently completed
prior to pregnancy and we therefore suggest that surveillance CMR be
offered to women with palliated complete TGA of child-bearing age in
advance of pregnancy, ideally at the time of preconceptual evaluation.
Furthermore, beyond quantiﬁcation of systemic EF, CMR can allow for
evaluation of additional parameters whichmay have clinical beneﬁt, in-
cluding response to pharmacologic stress, quantiﬁcation of TR, and in-
terrogation of bafﬂe integrity (although these data were not routinely
obtained in our study cohort and were therefore not reported). We
observed that, by and large, the women in our cohort had successful
outcomes of pregnancy with morbidities that were managed medically
with good effect; importantly there were nomaternal deaths in our co-
hort. Although it might be tempting to suggest that current guidelines
stating that women with atrial redirection surgery with more than
moderate RV systolic dysfunction should avoid pregnancy [8] are per-
haps too stringent, it should be noted that we did not have any patients
with severe systemic RV dysfunction (all patients studied had an RVEF
≥30%) and thosewith pacemakers/deﬁbrillatorswere excluded. Overall,
we believe that the ﬁndings of this study suggest that patients with at
least moderate RV systolic dysfunction should remain under close sur-
veillance for detection and treatment of adverse cardiovascular events
in pregnancy.
4.1. Study limitations
Several limitations of this study are worthy of mention. The retro-
spective construct and the small sample size of the study cohort are
noteworthy limitations of this study. The observed incidence of adverse
events in pregnancymay be affected by exclusion of patients withman-
ifest arrhythmias and indwelling pacemakers/deﬁbrillators (these pa-
tients are typically deemed unsuitable for CMR) and therefore those
excluded from the cohort may in fact represent the more severe end
of the disease spectrum. In addition, patients were selected from tertia-
ry care centers only, which may affect generalizability of the results.
However, given the complexity of this patient population, it is unlikely
that these patients would receive care in non-specialized centers. Pre
and post CMR imaging would have been useful for the evaluation of
the impact of pregnancy on systemic RV function, however there was
only one CMR available for each patient. Although CMR studies just
prior to the start of pregnancywould have been highly desirable, timing
of conception is often unpredictable and the safety of CMR study in the
ﬁrst trimester of pregnancy is currently unknown. Therefore, it is often
not possible to synchronize CMR prior pregnancy onset. We included
CMR studies completed within 2 years of pregnancy as some authors
have suggested that imaging is unlikely to change for themajoritywith-
in this time frame [21]. Further reassurance is provided by general sta-
bility of RV systolic function on echocardiography in this cohort.
Finally, long-term follow-up to assess the impact of pregnancy on theRV would be useful information but was not available in the majority
of the women studied.
Ideally, future studieswould allow for incorporation ofmultiple cen-
ters and would include longer follow-up to better understand the im-
pact of pregnancy on longer-term outcomes in this cohort of women.
Directions for future research would include prospective study of this
population with inclusion of additional measurements with potential
prognostic value in the adult patient with atrial redirection surgery, in-
cluding incorporation of biomarkers (such as brain natriuretic peptide
measurement before/during/after pregnancy), cardiopulmonary exer-
cise studies prior to pregnancy (formeasurement of heart rate response,
peak aerobic capacity etc.), and stress testing for determination of con-
tractile reserve in advance of conception.
5. Conclusion
While themajority ofwomen in this cohort had successful outcomes
during pregnancy, important cardiovascular complicationswere seen in
a subset of pregnancies, all with systemic RV systolic function b35%. The
prognostic value of CMRmeasurements in women following atrial redi-
rection surgery requires further study in a large cohort of women un-
dergoing pregnancy, preferably followed prospectively.
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